Volume 48, Issue 1 pp. 4-9
Review

Should ovarian cryopreservation be offered to girls with cancer

Michael Weintraub MD

Corresponding Author

Michael Weintraub MD

Pediatric Hematology-Oncology unit, Hadassah University Medical Center, Jerusalem, Israel

Pediatric Hematology-Oncology, Hadassah University Medical Center, Kiryat Hadassah, P.O. 12000 Jerusalem 91120, Israel.===Search for more papers by this author
Eitan Gross MD

Eitan Gross MD

Pediatric Surgery Department, Hadassah University Medical Center, Jerusalem, Israel

Search for more papers by this author
Avishag Kadari MD

Avishag Kadari MD

Department of Anaesthesiology, Hadassah University Medical Center, Jerusalem, Israel

Search for more papers by this author
Vardit Ravitsky PhD

Vardit Ravitsky PhD

Graduate Program in Bioethics, Bar Ilan University, Ramat Gan, Israel

Search for more papers by this author
Anat Safran PhD

Anat Safran PhD

Department of Obstetrics and Gynecology, Hadassah University Medical, Center, Jerusalem, Israel

Search for more papers by this author
Neri Laufer MD

Neri Laufer MD

Department of Obstetrics and Gynecology, Hadassah University Medical, Center, Jerusalem, Israel

Search for more papers by this author
Ariel Revel MD

Ariel Revel MD

Department of Obstetrics and Gynecology, Hadassah University Medical, Center, Jerusalem, Israel

Search for more papers by this author
First published: 07 July 2006
Citations: 36

Presented at the Israeli Fertility Society Meeting, Tel Aviv, 2003, and at the Israeli Society for Pediatric Hematology-Oncology, Tel Aviv, 2004

Abstract

Current therapy of childhood cancer makes long-term survival a realistic outcome for most patients. However, some treatment regimens entail a significant risk of infertility. No established method for preservation of female fertility is currently available. Ovarian cryopreservation is an experimental technology that is being offered with increasing frequency to women undergoing cancer therapy. It has not yet been reported in children and adolescent girls. The aim of this review is to stimulate discussion on the possibility of performing ovarian cryopreservation in pre-menarcheal girls in advance of therapies that may induce ovarian failure. We present a multi-disciplinary discussion of the risks and benefits associated with the procedure and propose guidelines for its implementation. We propose that all girls about to receive treatment that has a high risk for infertility be offered consultation about the possibility of ovarian cryopreservation. Pediatr Blood Cancer 2007;48:4–9. © 2006 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.